Sterling Investment Advisors Ltd. lowered its position in Tema Heart & Health ETF (NASDAQ:HRTS – Free Report) by 19.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 140,340 shares of the company’s stock after selling 33,938 shares during the quarter. Sterling Investment Advisors Ltd. owned approximately 8.94% of Tema Heart & Health ETF worth $4,343,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of HRTS. CoreCap Advisors LLC lifted its holdings in shares of Tema Heart & Health ETF by 25,280.4% during the 3rd quarter. CoreCap Advisors LLC now owns 51,776 shares of the company’s stock valued at $1,602,000 after buying an additional 51,572 shares during the last quarter. Oliver Lagore Vanvalin Investment Group acquired a new position in Tema Heart & Health ETF in the second quarter worth approximately $905,000. Jane Street Group LLC raised its position in Tema Heart & Health ETF by 9.4% during the second quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock valued at $1,062,000 after acquiring an additional 3,202 shares in the last quarter. Finally, JPMorgan Chase & Co. acquired a new stake in Tema Heart & Health ETF in the second quarter valued at approximately $63,000.
Tema Heart & Health ETF Stock Down 0.1%
Shares of HRTS opened at $35.81 on Friday. The firm has a market cap of $55.51 million, a price-to-earnings ratio of 22.06 and a beta of 0.97. The company’s fifty day moving average is $35.26 and its 200-day moving average is $31.95. Tema Heart & Health ETF has a 12 month low of $25.32 and a 12 month high of $36.63.
Tema Heart & Health ETF Announces Dividend
Tema Heart & Health ETF Company Profile
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.
Further Reading
- Five stocks we like better than Tema Heart & Health ETF
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Tema Heart & Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Heart & Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.
